900181851	900181851	CD	B-NP	O
|	|	NN	I-NP	O
BH	BH	NN	I-NP	O
|	|	NN	I-NP	O
05179465	05179465	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
7149040	7149040	CD	B-NP	O
|	|	CC	I-NP	O
3/20/2006	3/20/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CHF	CHF	NN	I-NP	I-protein
exacerbation	exacerbation	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/27/2006	3/27/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/5/2006	4/5/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
KOVALSKY	KOVALSKY	NNP	B-NP	O
,	,	,	O	O
TOBY	TOBY	NNP	B-NP	O
A	A	NNP	I-NP	O
522-03-89-2	522-03-89-2	POS	B-NP	B-DNA
Couarbprings	Couarbprings	NNP	I-NP	I-DNA
Gene	Gene	NNP	I-NP	I-DNA
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
8/20/06	8/20/06	CD	B-NP	O
AT	AT	NN	I-NP	O
05	05	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
VANDIS	VANDIS	NNP	B-NP	O
,	,	,	O	O
TERENCE	TERENCE	NNP	B-NP	O
ADRIAN	ADRIAN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
CPR	CPR	NN	I-NP	B-protein
,	,	,	O	O
No	No	DT	B-NP	O
defib	defib	NN	I-NP	O
,	,	,	O	O
No	No	DT	B-NP	O
intubation	intubation	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
325	325	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/29/06	10/29/06	CD	B-NP	O
by	by	IN	B-PP	O
STRAY	STRAY	NNP	B-NP	O
,	,	,	O	O
KELLY	KELLY	NNP	B-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
709558074	709558074	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
ALLOPURINOL	ALLOPURINOL	NN	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/29/06	10/29/06	CD	B-NP	O
by	by	IN	B-PP	O
HEISSE	HEISSE	NNP	B-NP	O
,	,	,	O	O
EUGENIO	EUGENIO	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ALLOPURINOL	ALLOPURINOL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
TESSALON	TESSALON	NN	I-NP	O
PERLES	PERLES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
BENZONATATE	BENZONATATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
20	20	CD	B-NP	O
NEXIUM	NEXIUM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
FERROUS	FERROUS	NNP	I-NP	O
SULFATE	SULFATE	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
4/24	4/24	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
milk	milk	NN	I-NP	O
and	and	CC	I-NP	O
antacid	antacid	NN	I-NP	O
GLIPIZIDE	GLIPIZIDE	NN	I-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
K-DUR	K-DUR	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
KCL	KCL	NNP	I-NP	O
SLOW	SLOW	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MEQ	MEQ	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
As	As	IN	B-PP	O
per	per	IN	B-PP	O
EH	EH	NNP	B-NP	O
Potassium	Potassium	NNP	I-NP	O
Chloride	Chloride	NNP	I-NP	O
Policy	Policy	NNP	I-NP	O
:	:	:	O	O
each	each	DT	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
with	with	IN	B-PP	O
4	4	CD	B-NP	O
oz	oz	NN	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	O
LEVOXYL	LEVOXYL	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/29/06	10/29/06	CD	B-NP	O
by	by	IN	B-PP	O
GARRAND	GARRAND	NNP	B-NP	O
,	,	,	O	O
ABRAHAM	ABRAHAM	NNP	B-NP	O
H.	H.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
ATIVAN	ATIVAN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
LORAZEPAM	LORAZEPAM	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
0.5	0.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Insomnia	Insomnia	NNP	I-NP	O
TOPROL	TOPROL	NNP	I-NP	O
XL	XL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
3	3	CD	B-NP	O
PRAVACHOL	PRAVACHOL	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
PRAVASTATIN	PRAVASTATIN	NN	I-NP	O
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BEDTIME	BEDTIME	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/29/06	10/29/06	CD	B-NP	O
by	by	IN	B-PP	O
LOEWEN	LOEWEN	NNP	B-NP	O
,	,	,	O	O
CEDRIC	CEDRIC	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
MULTIVITAMIN	MULTIVITAMIN	NN	B-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
120645473	120645473	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PRAVASTATIN	PRAVASTATIN	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/29/06	10/29/06	CD	B-NP	O
by	by	IN	B-PP	O
DENNY	DENNY	NNP	B-NP	O
,	,	,	O	O
DIRK	DIRK	NNP	B-NP	O
W.	W.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
709558074	709558074	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PRAVASTATIN	PRAVASTATIN	NN	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
MULTIVITAMIN	MULTIVITAMIN	NN	I-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
MULTIVI	MULTIVI	NN	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	SYM	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	B-protein
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/29/06	10/29/06	CD	B-NP	O
by	by	IN	B-PP	O
PENDON	PENDON	NNP	B-NP	O
,	,	,	O	O
DORSEY	DORSEY	NNP	B-NP	O
S.	S.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PRAVASTATIN	PRAVASTATIN	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
TORSEMIDE	TORSEMIDE	NN	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
4/24	4/24	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
COUMADIN	COUMADIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1	1	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QPM	QPM	NN	I-NP	O
Starting	Start	VBG	B-VP	O
NOW	NOW	RB	B-NP	O
-LRB-	-LRB-	JJ	I-NP	O
4/24	4/24	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
WITHIN	WITHIN	NN	B-NP	O
HOUR	HOUR	NN	I-NP	O
OF	OF	IN	B-PP	O
PHARMACY	PHARMACY	NNP	B-NP	O
APPROVAL	APPROVAL	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/29/06	10/29/06	CD	B-NP	O
by	by	IN	B-PP	O
COLTEY	COLTEY	NN	B-NP	O
,	,	,	O	O
ISMAEL	ISMAEL	NNP	B-NP	O
A.	A.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ALLOPURINOL	ALLOPURINOL	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
017670915	017670915	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ALLOPURINOL	ALLOPURINOL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/29/06	10/29/06	CD	B-NP	O
by	by	IN	B-PP	O
REATH	REATH	NN	B-NP	O
,	,	,	O	O
ERNESTO	ERNESTO	NN	B-NP	O
A.	A.	NN	I-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LEVOXYL	LEVOXYL	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
468611870	468611870	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/29/06	10/29/06	CD	B-NP	O
by	by	IN	B-PP	O
VITTORINI	VITTORINI	NNP	B-NP	O
,	,	,	O	O
BRENDON	BRENDON	NNP	B-NP	O
E.	E.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
049528289	049528289	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/29/06	10/29/06	CD	B-NP	O
by	by	IN	B-PP	O
WALMER	WALMER	NNP	B-NP	O
,	,	,	O	O
HOMER	HOMER	NNP	B-NP	O
T.	T.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PRAVASTATIN	PRAVASTATIN	NN	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
measure	measure	VB	I-VP	O
weight	weight	NN	B-NP	O
daily	daily	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
1800	1800	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Ezra	Ezra	NNP	I-NP	O
Eckford	Eckford	NNP	I-NP	O
8/3/06	8/3/06	CD	I-NP	O
@	@	NN	I-NP	O
11AM	11AM	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Cardiology	Cardiology	NNP	B-NP	O
clinic	clinic	NN	I-NP	O
for	for	IN	B-PP	O
blood	blood	NN	B-NP	O
work	work	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Dewell	Dewell	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
11/1/06	11/1/06	CD	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CHF	CHF	NNP	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
gastroesophageal	gastroesophageal	JJ	B-NP	O
reflux	reflux	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
hypothyroidism	hypothyroidism	NN	B-NP	O
,	,	,	O	O
mitral	mitral	JJ	B-NP	O
regurgitation	regurgitation	NN	I-NP	O
s/p	s/p	NN	I-NP	O
repair	repair	NN	I-NP	O
,	,	,	O	O
lung	lung	NN	B-NP	O
ca	ca	NN	I-NP	O
s/p	s/p	NN	I-NP	O
lobectomy	lobectomy	NN	I-NP	O
,	,	,	O	O
endometrial	endometrial	JJ	B-NP	O
ca	ca	NN	I-NP	O
s/p	s/p	NN	I-NP	O
TAH/BSO	TAH/BSO	NN	I-NP	O
,	,	,	O	O
basal	basal	JJ	B-NP	O
cell	cell	NN	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
,	,	,	O	O
renal	renal	JJ	B-NP	O
artery	artery	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
s/p	s/p	NN	I-NP	O
L	L	NN	I-NP	O
stent	stent	NN	I-NP	O
,	,	,	O	O
recurrent	recurrent	JJ	B-NP	O
flash	flash	NN	I-NP	O
pulm	pulm	NN	I-NP	O
edema	edema	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
IV	IV	CD	I-NP	O
diuretics	diuretic	NNS	I-NP	O
,	,	,	O	O
electrolyte	electrolyte	NN	B-NP	O
monitoring	monitoring	NN	I-NP	O
,	,	,	O	O
antibiotics	antibiotic	NNS	B-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
increasing	increase	VBG	B-NP	O
SOB	SOB	NN	I-NP	B-protein
,	,	,	O	O
weight	weight	NN	B-NP	O
gain	gain	NN	I-NP	O
*****	*****	SYM	B-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
75F	75F	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
h/o	h/o	NN	I-NP	O
CHF/CAD	CHF/CAD	NN	I-NP	O
,	,	,	O	O
a-fib	a-fib	NN	B-NP	B-DNA
,	,	,	O	O
lung	lung	NN	B-NP	O
CA	CA	NN	I-NP	O
s/p	s/p	NN	I-NP	O
R	R	NN	I-NP	O
wedge	wedge	NN	I-NP	O
resection	resection	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
admitted	admit	VBN	I-VP	O
5-6	5-6	CD	B-NP	O
times	time	NNS	I-NP	O
this	this	DT	B-NP	O
year	year	NN	I-NP	O
for	for	IN	B-PP	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
on	on	IN	B-PP	O
3/4	3/4	CD	B-NP	O
after	after	IN	B-PP	O
tx	tx	NN	B-NP	O
for	for	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
and	and	CC	I-NP	O
PNA	PNA	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
CHF	CHF	NN	I-NP	B-protein
RN	RN	NN	I-NP	I-protein
.	.	.	O	O

Over	Over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
3	3	CD	I-NP	O
days	day	NNS	I-NP	O
since	since	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
noticed	notice	VBN	I-VP	O
a	a	DT	B-NP	O
3lb	3lb	NN	I-NP	B-protein
weight	weight	NN	I-NP	I-protein
gain	gain	NN	I-NP	I-protein
.	.	.	O	O

Additionally	Additionally	RB	B-ADVP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
increasing	increase	VBG	B-NP	O
SOB	SOB	NN	I-NP	B-protein
,	,	,	O	O
poor	poor	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
.	.	.	O	O

Stable	Stable	JJ	B-NP	O
2	2	CD	I-NP	O
pillow	pillow	NN	I-NP	O
orthopnea	orthopnea	NN	I-NP	O
but	but	CC	O	O
more	more	RBR	B-NP	O
comfortable	comfortable	JJ	I-NP	O
sitting	sit	VBG	I-NP	O
bent	bent	NN	I-NP	O
over	over	RB	B-ADVP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
waist	waist	NN	I-NP	O
.	.	.	O	O

Per	Per	IN	B-PP	O
her	her	PRP$	B-NP	O
PCP	PCP	NN	I-NP	O
's	's	POS	B-NP	O
instructions	instruction	NNS	I-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
increased	increase	VBD	B-VP	O
Torsemide	Torsemide	NN	B-NP	O
to	to	TO	B-PP	O
40mg	40mg	CD	B-NP	O
BID	BID	NN	I-NP	O
which	which	WDT	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
increase	increase	VB	I-VP	O
her	her	PRP$	B-NP	O
UOP	UOP	NN	I-NP	B-protein
.	.	.	O	O

ROS	ROS	NN	B-NP	O
:	:	:	O	O
+	+	SYM	B-NP	O
SOB	SOB	NN	I-NP	B-protein
+	+	SYM	B-NP	O
PND	PND	NN	I-NP	O
+	+	SYM	I-NP	O
orthopnea	orthopnea	NN	I-NP	O
+	+	SYM	I-NP	O
bilat	bilat	NN	I-NP	O
LE	LE	NN	I-NP	O
swelling	swelling	NN	I-NP	O
,	,	,	O	O
brief	brief	JJ	B-NP	O
CP	CP	NN	I-NP	B-DNA
,	,	,	O	O
+	+	CC	O	O
diarrhea	diarrhea	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
2	2	CD	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
palpitations/dizziness	palpitations/dizziness	NN	I-NP	O
.	.	.	O	O

*****	*****	SYM	O	O
In	In	IN	B-PP	O
ED	ED	NN	B-NP	O
:	:	:	O	O
T95	T95	NN	B-NP	O
.6	.6	CD	I-NP	O
P74	P74	NN	I-NP	O
BP118/65	BP118/65	NN	I-NP	O
RR10	RR10	NN	I-NP	O
SaO2	SaO2	NN	I-NP	O
on	on	IN	B-PP	O
98	98	CD	B-NP	O
on	on	IN	B-PP	O
RA	RA	NN	B-NP	B-protein
Pt	Pt	NN	I-NP	I-protein
received	receive	VBD	B-VP	I-protein
40	40	CD	B-NP	I-protein
Lasix	Lasix	NNP	I-NP	I-protein
IV	IV	CD	I-NP	I-protein
.	.	.	O	O

***	***	SYM	O	O
Home	Home	NNP	B-NP	O
Medications	Medication	NNPS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

ASA	ASA	NN	B-NP	O
325	325	CD	I-NP	O
,	,	,	O	O
Allopurinol	Allopurinol	NNP	B-NP	O
100	100	CD	I-NP	O
,	,	,	O	O
Nexium	Nexium	NN	B-NP	B-protein
20	20	CD	I-NP	I-protein
,	,	,	O	O
Iron	Iron	NNP	B-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Glipizide	Glipizide	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
BID	BID	NNP	I-NP	O
,	,	,	O	O
K-dur	K-dur	NNP	B-NP	O
20	20	CD	I-NP	O
BID	BID	NNP	I-NP	O
,	,	,	I-NP	O
Levoxyl	Levoxyl	NNP	I-NP	O
100	100	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
,	,	,	I-NP	O
Lorazepam	Lorazepam	NNP	I-NP	O
0.5	0.5	CD	I-NP	O
MG	MG	NN	I-NP	O
QD	QD	NN	I-NP	O
prn	prn	NN	I-NP	O
,	,	,	O	O
Toprol	Toprol	NNP	B-NP	O
Xl	Xl	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
,	,	,	I-NP	O
MVI	MVI	NNP	I-NP	O
,	,	,	I-NP	O
pravastatin	pravastatin	NN	I-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
QHS	QHS	NNP	B-NP	O
,	,	,	O	O
Torsemide	Torsemide	NNP	B-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
BID	BID	NNP	I-NP	O
,	,	,	O	O
Coumadin	Coumadin	NNP	B-NP	O
1	1	CD	I-NP	O
MG	MG	NN	I-NP	O
***	***	SYM	I-NP	O
Allergies	Allergy	NNPS	I-NP	O
:	:	:	O	O
NKDA	NKDA	NN	B-NP	B-protein
****	****	SYM	O	O
PMH	PMH	NN	B-NP	O
:	:	:	O	O
CRI	CRI	NN	B-NP	O
,	,	,	O	O
hypothyroidism	hypothyroidism	NN	B-NP	O
,	,	,	O	O
paroxysmal	paroxysmal	JJ	B-NP	O
a-fib	a-fib	NN	I-NP	O
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
lung	lung	NN	B-NP	O
CA	CA	NN	I-NP	O
s/p	s/p	NN	I-NP	O
R	R	NN	I-NP	O
wedge	wedge	NN	I-NP	O
resection	resection	NN	I-NP	O
,	,	,	O	O
basal	basal	JJ	B-NP	O
cell	cell	NN	I-NP	O
CA	CA	NN	I-NP	O
on	on	IN	B-PP	O
lip	lip	NN	B-NP	O
s/p	s/p	NN	I-NP	O
resection	resection	NN	I-NP	O
,	,	,	O	O
uterine	uterine	JJ	B-NP	O
CA	CA	NN	I-NP	O
s/pTAH	s/pTAH	NN	I-NP	O
.	.	.	O	O

***	***	SYM	B-NP	O
FHx	FHx	NN	I-NP	O
:	:	:	O	O
non	non	JJ	B-NP	O
contrib	contrib	NN	I-NP	O
***	***	SYM	O	O
Social	Social	NNP	B-NP	O
:	:	:	O	O
Lives	Live	VBZ	B-VP	O
with	with	IN	B-PP	O
husband	husband	NN	B-NP	O
across	across	IN	B-PP	O
street	street	NN	B-NP	O
from	from	IN	B-PP	O
UOUMC	UOUMC	NN	B-NP	B-cell_type
.	.	.	O	O

+	+	SYM	O	O
tob	tob	NN	B-NP	O
history	history	NN	I-NP	O
,	,	,	O	O
-	-	HYPH	B-NP	O
EtOH	EtOH	NN	I-NP	B-protein
,	,	,	O	O
-	-	HYPH	B-NP	O
IVDU	IVDU	NN	I-NP	O
***	***	SYM	B-NP	O
PE	PE	NN	I-NP	O
on	on	IN	B-PP	O
admit	admit	NN	B-NP	O
:	:	:	O	O
VS	VS	NN	B-NP	O
:	:	:	O	O
T	T	NN	B-NP	O
:	:	:	O	O
95.6	95.6	CD	B-NP	O
P74	P74	NN	I-NP	O
BP	BP	NN	I-NP	O
:	:	:	O	O
118	118	CD	B-NP	O
/	/	SYM	I-NP	O
75	75	CD	I-NP	O
RR10	RR10	NN	I-NP	O
SaO2	SaO2	NN	I-NP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
RA	RA	NN	B-NP	O
,	,	,	O	O
JVP	JVP	NN	B-NP	O
15cm	15cm	NN	I-NP	O
C/V	C/V	NN	I-NP	O
irreg	irreg	NN	I-NP	O
irreg	irreg	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
m/g/r	m/g/r	NN	I-NP	B-protein
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
crackles	crackle	NNS	I-NP	O
at	at	IN	B-PP	O
R	R	NN	B-NP	B-protein
base	base	NN	I-NP	I-protein
.	.	.	O	O

Legs	Leg	NNS	B-NP	B-protein
2	2	CD	I-NP	I-protein
+	+	SYM	I-NP	O
LE	LE	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

+	+	SYM	O	O
tenderness	tenderness	NN	B-NP	O
on	on	IN	B-PP	O
L	L	NN	B-NP	O
shin/bruise	shin/bruise	NN	I-NP	O
,	,	,	O	O
AAOx3	AAOx3	NN	B-NP	O
CXR	CXR	NN	I-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
pulm	pulm	NN	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
improved	improve	VBD	B-VP	O
RLL	RLL	NNP	B-NP	O
PNA	PNA	NNP	I-NP	O
****	****	NNP	I-NP	O
PE	PE	NNP	I-NP	O
on	on	IN	B-PP	O
Discharge	Discharge	NNP	B-NP	O
-	-	HYPH	B-NP	O
97.7	97.7	CD	I-NP	O
P65-84	P65-84	NN	I-NP	O
BP	BP	NN	I-NP	O
90-108/50	90-108/50	CD	B-NP	O
RR18	RR18	NN	I-NP	O
93-97	93-97	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
RA	RA	NN	B-NP	O
,	,	,	O	O
A	A	NNP	B-NP	B-protein
&	&	CC	I-NP	I-protein
OX	OX	NNP	I-NP	I-protein
3	3	CD	I-NP	I-protein
,	,	,	O	O
more	more	RBR	B-NP	O
solid	solid	JJ	I-NP	O
stool	stool	NN	I-NP	O
,	,	,	O	O
lungs	lung	VBZ	B-VP	O
CTA	CTA	NN	B-NP	B-protein
on	on	IN	B-PP	O
left	left	NN	B-NP	O
,	,	,	O	O
decreased	decrease	VBD	B-VP	O
breath	breath	NN	B-NP	O
sounds	sound	NNS	I-NP	O
on	on	IN	B-PP	O
right	right	NN	B-NP	O
,	,	,	O	O
JVP	JVP	NN	B-NP	O
8cm	8cm	NN	I-NP	O
,	,	,	O	O
CV	CV	NN	B-NP	O
irreg	irreg	NN	I-NP	O
irreg	irreg	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
on	on	IN	B-PP	O
R	R	NN	B-NP	O
,	,	,	O	O
3	3	CD	B-NP	O
+	+	SYM	B-VP	O
on	on	IN	B-PP	O
LLE	LLE	NN	B-NP	O
****	****	SYM	I-NP	O
Studies	Study	NNS	I-NP	O
:	:	:	O	O
LENI	LENI	NN	B-NP	B-protein
4/30	4/30	CD	I-NP	I-protein
-	-	HYPH	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	B-protein
in	in	IN	B-PP	O
left	left	JJ	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
C	C	NN	I-NP	O
Diff	Diff	NN	I-NP	O
negative	negative	JJ	I-NP	O
****	****	NN	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Course	Course	NNP	I-NP	O
:	:	:	O	O
75F	75F	NN	B-NP	O
with	with	IN	B-PP	O
h/o	h/o	NN	B-NP	B-protein
CAD/CHF/lung	CAD/CHF/lung	NN	I-NP	I-protein
CA/Afib	CA/Afib	NN	I-NP	I-protein
with	with	IN	B-PP	O
3	3	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
weight	weight	NN	B-NP	O
gain	gain	NN	I-NP	O
,	,	,	O	O
worsening	worsen	VBG	B-VP	O
SOB	SOB	NN	B-NP	B-protein
and	and	CC	I-NP	O
orthopnea	orthopnea	NN	I-NP	O
.	.	.	O	O

1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
CHF	CHF	NN	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
of	of	IN	B-PP	O
heart	heart	NN	B-NP	O
failure	failure	NN	I-NP	O
--	--	:	O	O
PND	PND	NN	B-NP	O
,	,	,	O	O
elevated	elevated	JJ	B-NP	O
JVP	JVP	NN	I-NP	O
and	and	CC	O	O
bilateral	bilateral	JJ	B-NP	O
LE	LE	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
clinic	clinic	JJ	I-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
syndrome	syndrome	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
CAD	CAD	NN	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
BB	BB	NN	B-NP	B-protein
,	,	,	O	O
asa	asa	NN	B-NP	O
,	,	,	O	O
statin	statin	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
,	,	,	O	O
initially	initially	RB	B-ADVP	O
with	with	IN	B-PP	O
lasix	lasix	CD	B-NP	O
40mg	40mg	CD	I-NP	O
IV	IV	CD	I-NP	O
then	then	RB	B-ADVP	O
80mg	80mg	CD	B-NP	O
IV	IV	CD	I-NP	O
with	with	IN	B-PP	O
excellent	excellent	JJ	B-NP	O
results	result	NNS	I-NP	O
--	--	:	O	O
>	>	SYM	B-NP	O
1L	1L	NN	I-NP	O
negative	negative	JJ	B-ADJP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
BID	BID	NN	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
weight	weight	NN	I-NP	O
remained	remain	VBD	B-VP	O
unchanged	unchanged	JJ	B-ADJP	O
at	at	IN	B-PP	O
165lb	165lb	NN	B-NP	B-DNA
.	.	.	O	O

At	At	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
continuing	continue	VBG	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
net	net	JJ	B-NP	O
negative	negative	JJ	B-ADJP	O
on	on	IN	B-PP	O
po	po	NN	B-NP	O
torsemide	torsemide	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
with	with	IN	B-PP	O
torsemide	torsemide	NN	B-NP	O
80mg	80mg	NN	I-NP	O
BID	BID	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
have	have	VB	I-VP	O
close	close	JJ	B-NP	O
VNA	VNA	NN	I-NP	O
and	and	CC	I-NP	O
electrolyte	electrolyte	NN	I-NP	O
follow-up	follow-up	NN	I-NP	O
.	.	.	O	O

Dry	Dry	NN	B-NP	O
weight	weight	NN	I-NP	O
goal	goal	NN	I-NP	O
previously	previously	RB	B-ADVP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
155-157lb	155-157lb	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	O	O
given	give	VBN	B-PP	O
the	the	DT	B-NP	O
resolution	resolution	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
and	and	CC	O	O
overall	overall	JJ	B-NP	O
clinical	clinical	JJ	I-NP	O
picture	picture	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
above	above	IN	B-PP	O
her	her	PRP$	B-NP	O
dry	dry	JJ	I-NP	O
weight	weight	NN	I-NP	O
with	with	IN	B-PP	O
close	close	JJ	B-NP	O
follow-up	follow-up	NN	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Afib	Afib	NNP	I-NP	O
--	--	:	O	O
continue	continue	VBP	B-VP	O
coumadin	coumadin	NN	B-NP	O
1mg	1mg	NN	I-NP	O
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
is	be	VBZ	B-VP	O
2.1	2.1	CD	B-NP	O
3	3	CD	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
PNA	PNA	NN	I-NP	B-protein
-	-	HYPH	B-NP	O
Recent	Recent	JJ	I-NP	O
RLL	RLL	NN	I-NP	O
PNA	PNA	NN	I-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
completed	complete	VBD	B-VP	O
course	course	NN	B-NP	O
of	of	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
and	and	CC	I-NP	O
cefpodoxime	cefpodoxime	NN	I-NP	O
.	.	.	O	O

Diarrhea	Diarrhea	NNP	B-NP	O
likely	likely	RB	B-NP	O
antibiotic	antibiotic	NN	I-NP	O
associated	associate	VBN	B-VP	O
,	,	,	O	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
C	C	NN	B-NP	O
diff	diff	NN	I-NP	O
and	and	CC	O	O
responded	respond	VBD	B-VP	O
to	to	TO	B-PP	O
lactobacillus	lactobacillus	NN	B-NP	O
supplements	supplement	NNS	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Anemia	Anemia	NN	I-NP	O
:	:	:	O	O
Chronic	Chronic	JJ	B-NP	O
iron	iron	NN	I-NP	O
deficiency	deficiency	NN	I-NP	O
.	.	.	O	O

HCT	HCT	NN	B-NP	B-cell_line
28.7	28.7	CD	I-NP	I-cell_line
but	but	CC	O	O
elected	elect	VBD	B-VP	O
not	not	RB	O	O
to	to	TO	B-VP	O
transfuse	transfuse	VB	I-VP	O
.	.	.	O	O

Continue	Continue	JJ	B-NP	O
iron	iron	NN	I-NP	O
supplement	supplement	NN	I-NP	O
.	.	.	O	O

5	5	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
FEN	FEN	NN	I-NP	B-protein
-	-	HYPH	O	O
Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
compliant	compliant	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
1.5	1.5	CD	I-NP	O
L	L	NN	I-NP	O
fluid	fluid	NN	I-NP	O
restriction	restriction	NN	I-NP	O
and	and	CC	O	O
<	<	SYM	B-NP	O
2g	2g	CD	I-NP	O
salt	salt	NN	I-NP	O
cardiac	cardiac	JJ	I-NP	O
diabetic	diabetic	JJ	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Diabetes	Diabetes	NNP	I-NP	O
-	-	HYPH	I-NP	O
Was	Was	NNP	I-NP	O
managed	manage	VBD	B-VP	O
on	on	IN	B-PP	O
lantus/novolog	lantus/novolog	NN	B-NP	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
resume	resume	VB	I-VP	O
oral	oral	JJ	B-NP	O
DM	DM	NN	I-NP	O
meds	med	NNS	I-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Continued	Continued	NNP	B-NP	O
Levoxyl	Levoxyl	NNP	I-NP	O
100meq	100meq	NN	I-NP	O
.	.	.	O	O

Recent	Recent	JJ	B-NP	O
TSH	TSH	NN	I-NP	O
8/22	8/22	CD	I-NP	O
wnl	wnl	NN	I-NP	O
.	.	.	O	O

Continue	Continue	JJ	B-NP	O
allopurinol	allopurinol	NN	I-NP	O
for	for	IN	B-PP	O
presumed	presume	VBN	B-NP	O
gout	gout	NN	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
During	During	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
you	you	PRP	B-NP	O
were	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
for	for	IN	B-PP	O
heart	heart	NN	B-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
should	should	MD	B-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
monitor	monitor	VB	I-VP	O
your	your	PRP$	B-NP	O
diet	diet	NN	I-NP	O
and	and	CC	I-NP	O
salt	salt	NN	I-NP	O
intake	intake	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
increased	increase	VBN	I-VP	O
your	your	PRP$	B-NP	O
diuretic	diuretic	JJ	I-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-VP	O
torsemide	torsemide	VB	I-VP	O
80mg	80mg	NN	B-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
have	have	VB	I-VP	O
your	your	PRP$	B-NP	O
blood	blood	NN	I-NP	O
electrolytes	electrolyte	NNS	I-NP	O
checked	check	VBD	B-VP	O
in	in	IN	B-PP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
any	any	DT	B-NP	O
chest	ch	JJS	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
worsening	worsen	VBG	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
any	any	DT	B-NP	O
other	other	JJ	I-NP	O
concerning	concern	VBG	I-NP	O
symptom	symptom	NN	I-NP	O
call	call	VB	B-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
or	or	CC	O	O
go	go	VB	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ER	ER	NN	I-NP	B-protein
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

VNA	VNA	NN	B-NP	O
services	service	NNS	I-NP	O
for	for	IN	B-PP	O
cardiopulmonary	cardiopulmonary	JJ	B-NP	O
assessment	assessment	NN	I-NP	O
,	,	,	O	O
weight	weight	NN	B-NP	O
monitoring	monitoring	NN	I-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	B-protein
failure	failure	NN	I-NP	I-protein
monitoring	monitor	VBG	B-VP	I-protein
2	2	CD	B-NP	I-protein
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
torsemide	torsemide	NN	B-NP	O
80	80	CD	I-NP	O
BID	BID	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
her	her	PRP$	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
checked	check	VBD	B-VP	O
in	in	IN	B-PP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Babrow	Babrow	NNP	I-NP	O
with	with	IN	B-PP	O
Virgbaxt	Virgbaxt	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
No	No	NNP	I-NP	O
dictated	dictate	VBD	B-VP	O
summary	summary	JJ	B-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
HALSALL	HALSALL	NNP	B-NP	O
,	,	,	O	O
REY	REY	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DG15	DG15	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
8/20/06	8/20/06	CD	I-NP	O
@	@	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
43	43	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

